Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives.
about
Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat)Yi-Qi-Zeng-Min-Tang, a Chinese medicine, ameliorates insulin resistance in type 2 diabetic rats.Dual system for the central nervous system targeting and blood-brain barrier transport of a selective prolyl oligopeptidase inhibitor.Antidiabetic activity of the ethyl acetate fraction of Ficus lutea (Moraceae) leaf extract: comparison of an in vitro assay with an in vivo obese mouse model.Swim Training Improves HOMA-IR in Type 2 Diabetes Induced by High Fat Diet and Low Dose of Streptozotocin in Male Rats.Structured self-management education maintained over two years in insufficiently controlled type 2 diabetes patients: the ERMIES randomised trial in Reunion IslandCombination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet.Pleiotropic effects of thiazolidinediones.Caloric restriction or telmisartan control dyslipidemia and nephropathy in obese diabetic Zücker rats.Sitagliptin prevents aggravation of endocrine and exocrine pancreatic damage in the Zucker Diabetic Fatty rat - focus on amelioration of metabolic profile and tissue cytoprotective propertiesHomeostasis and compensatory homeostasis: bridging Western medicine and traditional chinese medicine.The incretin system ABCs in obesity and diabetes - novel therapeutic strategies for weight loss and beyond.Physical activity energy expenditure vs cardiorespiratory fitness level in impaired glucose metabolism.Polymorphism rs189037C > T in the promoter region of the ATM gene may associate with reduced risk of T2DM in older adults in China: a case control study.Pancreatic islet regeneration through PDX-1/Notch-1/Ngn3 signaling after gastric bypass surgery in db/db mice.Effect of aspirin on the expression of hepatocyte NF-κB and serum TNF-α in streptozotocin-induced type 2 diabetic rats.Mycobacterium avium subspecies paratuberculosis is not associated with type-2 diabetes mellitusClinical pharmacology of alogliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of Type 2 diabetes.Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes.Association between a gene variant near ataxia telangiectasia mutated and coronary artery disease in men.Comparative in vitro-in vivo correlation analysis with pioglitazone tablets
P2860
Q34003019-DD45E115-B40E-4829-B564-324F85263DA4Q34671018-FED41A68-50AE-4C8D-BCA4-1E63B9BDC2E3Q34871594-76EA10D7-38FE-4500-B16B-A103097353CDQ35974390-E4D70832-1FA2-4ADE-8BF9-BCCBB6EC135EQ36196044-2AE75121-6E5D-4FA5-9E27-D7079E070D8EQ36510146-B4618B85-65B8-437B-AF33-3F6BE283C730Q36835802-5A9F2D0D-C238-4F32-A814-C69337CAEE70Q37142044-969BDE83-6C2A-4452-95AD-05C92D824D32Q37532435-5B04E399-7E38-4E3D-825C-35A3D367A8BAQ37720797-4B8B0562-DD35-4F97-9F9E-73A5B3B15C7BQ37980441-964334B4-5661-4F0E-9F53-73FDFE76B3F7Q38820260-7EA3082B-C60F-4310-BD2B-64C65C871830Q40570455-A48E961F-03DC-41F0-97D4-F531625C936CQ41408548-71714BDF-5FEB-4BA7-9D8D-43FA73EB3A7AQ41872123-7DD6ED47-59C3-4123-B303-7FEFD9861743Q41968340-9E5C2137-96C8-441A-9C38-BC624924872AQ42171590-DC181749-1FEB-4F72-BD0E-BA67FB8E0E60Q42723596-A94C3691-BFD6-479E-A3DA-3E8DE4035ACAQ42876331-3E155AEA-2F7E-47CC-96C4-B6F84925CCB7Q51138265-8FCED9DE-EF56-49B4-B358-2C4BB9042DD3Q57932324-4BA43017-CC1C-40DC-82A5-1F1054B68FA1
P2860
Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Type 2 diabetes mellitus: epid ...... nd therapeutical perspectives.
@ast
Type 2 diabetes mellitus: epid ...... nd therapeutical perspectives.
@en
type
label
Type 2 diabetes mellitus: epid ...... nd therapeutical perspectives.
@ast
Type 2 diabetes mellitus: epid ...... nd therapeutical perspectives.
@en
prefLabel
Type 2 diabetes mellitus: epid ...... nd therapeutical perspectives.
@ast
Type 2 diabetes mellitus: epid ...... nd therapeutical perspectives.
@en
P2093
P1476
Type 2 diabetes mellitus: epid ...... nd therapeutical perspectives.
@en
P2093
P304
P356
10.1016/J.DIABET.2007.07.001
P577
2007-08-20T00:00:00Z